Literature DB >> 31802437

All that a physician should know about FODMAPs.

Wajiha Mehtab1,2, Ashish Agarwal2, Namrata Singh2, Anita Malhotra3, Govind K Makharia4.   

Abstract

A diet low in poorly absorbed, fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) is now considered as an effective strategy for symptoms control in patients with irritable bowel syndrome (IBS). The low FODMAP diet is administered in three phases, namely restriction of all dietary FODMAPs followed by rechallenge and then reintroduction of specific FODMAPs according to the tolerance of patients. A dietician should be involved in patients in whom a low FODMAP diet is planned. While restricting high FODMAPs, it is pertinent that patients are advised a well-balanced diet and suitable alternatives with low FODMAP contents in each food groups are prescribed. Strict adherence to a low FODMAP diet has been shown to improve symptoms, stool output, quality of life, and the overall well-being of patients with IBS. For those who do not respond to this dietary approach, a normal diet may be initiated and other treatment strategies (dietary or nondietary) should be considered. Interestingly, the low FODMAP diet has also been tried in other functional disorders, nonceliac gluten sensitivity, and even inflammatory bowel disease. Since the concept of FODMAP is relatively new, there is only limited data on the content of FODMAP in the Indian food items and there is a need to address this question. There is also a need for well-designed and adequately powered studies to explore the efficacy of low FODMAP diet in patients with IBS. In the present review article, we have compiled all the relevant information about FODMAPs with an objective to provide comprehensive information on FODMAPs to a physician.

Entities:  

Keywords:  Adherence; Balanced diet; FODMAP diet; Irritable bowel syndrome

Mesh:

Substances:

Year:  2019        PMID: 31802437     DOI: 10.1007/s12664-019-01002-0

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  58 in total

Review 1.  Gluten-free diet: the medical and nutrition management of celiac disease.

Authors:  Jacalyn See; Joseph A Murray
Journal:  Nutr Clin Pract       Date:  2006-02       Impact factor: 3.080

2.  Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon.

Authors:  J S Barrett; R B Gearry; J G Muir; P M Irving; R Rose; O Rosella; M L Haines; S J Shepherd; P R Gibson
Journal:  Aliment Pharmacol Ther       Date:  2010-01-22       Impact factor: 8.171

3.  Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.

Authors:  Richard B Gearry; Peter M Irving; Jacqueline S Barrett; Debbie M Nathan; Sue J Shepherd; Peter R Gibson
Journal:  J Crohns Colitis       Date:  2008-12-06       Impact factor: 9.071

4.  Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.

Authors:  Natalia Pedersen; Nynne Nyboe Andersen; Zsuzsanna Végh; Lisbeth Jensen; Dorit Vedel Ankersen; Maria Felding; Mette Hestetun Simonsen; Johan Burisch; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

5.  Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome.

Authors:  Jianfeng Yang; Yanyong Deng; Hua Chu; Yanqun Cong; Jianmin Zhao; Daniel Pohl; Benjamin Misselwitz; Michael Fried; Ning Dai; Mark Fox
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-13       Impact factor: 11.382

6.  Irritable bowel syndrome: a review and update.

Authors:  Kaitlin Occhipinti; James W Smith
Journal:  Clin Colon Rectal Surg       Date:  2012-03

7.  The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

Authors:  R H de Roest; B R Dobbs; B A Chapman; B Batman; L A O'Brien; J A Leeper; C R Hebblethwaite; R B Gearry
Journal:  Int J Clin Pract       Date:  2013-05-23       Impact factor: 2.503

8.  Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.

Authors:  Louise Maagaard; Dorit V Ankersen; Zsuzsanna Végh; Johan Burisch; Lisbeth Jensen; Natalia Pedersen; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 9.  Gluten free diet and nutrient deficiencies: A review.

Authors:  Giorgia Vici; Luca Belli; Massimiliano Biondi; Valeria Polzonetti
Journal:  Clin Nutr       Date:  2016-05-07       Impact factor: 7.324

10.  Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.

Authors:  Ruth M Harvie; Alexandra W Chisholm; Jordan E Bisanz; Jeremy P Burton; Peter Herbison; Kim Schultz; Michael Schultz
Journal:  World J Gastroenterol       Date:  2017-07-07       Impact factor: 5.742

View more
  5 in total

Review 1.  Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome.

Authors:  Andrew Thomas; Annie Thomas; Madeline Butler-Sanchez
Journal:  Am J Lifestyle Med       Date:  2021-05-10

Review 2.  A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis.

Authors:  Ziheng Peng; Jun Yi; Xiaowei Liu
Journal:  Nutrients       Date:  2022-05-15       Impact factor: 6.706

3.  FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction through Fermentation.

Authors:  Johannes Pitsch; Georg Sandner; Jakob Huemer; Maximilian Huemer; Stefan Huemer; Julian Weghuber
Journal:  Foods       Date:  2021-04-19

4.  Self-reported Wheat Sensitivity in Irritable Bowel Syndrome and Healthy Subjects: Prevalence of Celiac Markers and Response to Wheat-free Diet.

Authors:  Pavan Dhoble; Philip Abraham; Devendra Desai; Anand Joshi; Tarun Gupta; Shachish Doctor; Anand Deshpande; Rajeshwari Basavanna
Journal:  J Neurogastroenterol Motil       Date:  2021-10-30       Impact factor: 4.924

Review 5.  Postinfection Irritable Bowel Syndrome.

Authors:  Uday C Ghoshal
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.